MIST vs. ALT
MIST (Milestone Pharmaceuticals Inc.) and ALT (Altimmune, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 5 years, MIST returned -26.09%/yr vs -28.96%/yr for ALT. At a 0.20 correlation, their price movements are largely independent.
Performance
MIST vs. ALT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, MIST achieves a -35.15% return, which is significantly lower than ALT's -18.84% return.
MIST
- 1D
- 0.77%
- 1M
- -7.09%
- YTD
- -35.15%
- 6M
- -36.71%
- 1Y
- -22.49%
- 3Y*
- -25.36%
- 5Y*
- -26.09%
- 10Y*
- —
ALT
- 1D
- 8.52%
- 1M
- 1.03%
- YTD
- -18.84%
- 6M
- -29.23%
- 1Y
- -58.32%
- 3Y*
- -9.17%
- 5Y*
- -28.96%
- 10Y*
- -28.57%
MIST vs. ALT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
MIST Milestone Pharmaceuticals Inc. | -35.15% | -14.41% | 41.32% | -57.83% | -39.54% | -2.24% | -58.15% | 2.56% |
ALT Altimmune, Inc. | -18.84% | -49.93% | -35.91% | -31.61% | 79.59% | -18.79% | 496.83% | -36.79% |
Correlation
The correlation between MIST and ALT is 0.40, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.40 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.31 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.26 |
Correlation (All Time) Calculated using the full available price history since May 9, 2019 | 0.20 |
Over the past year, MIST and ALT have become more correlated (0.40) than their long-term average of 0.20, meaning their price movements have been converging.
Fundamentals
MIST:
$170.67M
ALT:
$364.67M
MIST:
-$0.49
ALT:
-$0.92
MIST:
63.69
ALT:
8.06K
MIST:
4.73
ALT:
1.28
MIST:
$1.78M
ALT:
$36.00K
MIST:
$1.75M
ALT:
-$14.92M
MIST:
-$63.04M
ALT:
-$93.48M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
MIST vs. ALT — Risk / Return Rank
MIST
ALT
MIST vs. ALT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Milestone Pharmaceuticals Inc. (MIST) and Altimmune, Inc. (ALT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| MIST | ALT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.38 | ||
| Sortino ratioReturn per unit of downside risk | +0.71 | ||
| Omega ratioGain probability vs. loss probability | 1.03 | 0.91 | +0.11 |
| Calmar ratioReturn relative to maximum drawdown | -0.34 | -0.88 | +0.54 |
| Martin ratioReturn relative to average drawdown | -0.63 | -1.16 | +0.53 |
Loading charts...
Drawdowns
MIST vs. ALT - Drawdown Comparison
The maximum MIST drawdown since its inception was -97.60%, roughly equal to the maximum ALT drawdown of -99.63%. Use the drawdown chart below to compare losses from any high point for MIST and ALT.
Loading charts...
Drawdown Indicators
| MIST | ALT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -97.60% | -99.63% | +2.03% |
Max Drawdown (1Y)Largest decline over 1 year | -65.76% | -66.41% | +0.65% |
Max Drawdown (3Y)Largest decline over 3 years | -82.31% | -81.25% | -1.06% |
Max Drawdown (5Y)Largest decline over 5 years | -93.13% | -90.45% | -2.68% |
Max Drawdown (10Y)Largest decline over 10 years | — | -99.63% | — |
Current DrawdownCurrent decline from peak | -95.17% | -99.29% | +4.12% |
Average DrawdownAverage peak-to-trough decline | -78.34% | -78.91% | +0.57% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 35.63% | 50.09% | -14.46% |
Volatility
MIST vs. ALT - Volatility Comparison
The current volatility for Milestone Pharmaceuticals Inc. (MIST) is 12.76%, while Altimmune, Inc. (ALT) has a volatility of 14.12%. This indicates that MIST experiences smaller price fluctuations and is considered to be less risky than ALT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| MIST | ALT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 12.76% | 14.12% | -1.36% |
Volatility (6M)Calculated over the trailing 6-month period | 54.45% | 60.60% | -6.15% |
Volatility (1Y)Calculated over the trailing 1-year period | 83.41% | 90.63% | -7.22% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 77.73% | 94.20% | -16.47% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 105.01% | 149.74% | -44.73% |
Dividends
MIST vs. ALT - Dividend Comparison
Neither MIST nor ALT has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
ALT Altimmune, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 1,462.31% |
MIST Milestone Pharmaceuticals Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
MIST vs. ALT - Financials Comparison
This section allows you to compare key financial metrics between Milestone Pharmaceuticals Inc. and Altimmune, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
MIST and ALT have a correlation of 0.40, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ALT has higher volatility (14.12%) compared to MIST (12.76%). In terms of maximum drawdown, MIST dropped -97.60% vs ALT's -99.63%.
MIST currently has the higher Sharpe Ratio (-0.27 vs -0.65), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for MIST and ALT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer